iZafe Group
STOCKHOLM, SWEDEN / ACCESSWIRE / December 8, 2023 / iZafe Group (STO:IZAFE-B) ("iZafe Group") announces that it has been awarded a contract in a procurement with the Municipality of Helsingborg for the provision of iZafe's pharmaceutical dispensers, Dosell. The procurement includes 150-400 units, with an estimated value of SEK 5.5-13.8 million. The contract is owned by Dosell AB, a wholly-owned subsidiary of iZafe Group.
The contract period is two years with the possibility of an additional two-year extension, and the contract will be signed no earlier than 10 days after the award, the time required by procurement rules to elapse before a contract can be signed.
This is merely a decision of award and is not legally binding until a contract has been entered into.
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm
E-mail: ir@izafegroup.com
www.izafegroup.com
eucaps.com/izafe-group
About iZafe Group AB (publ.)
iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.
The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.
The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.
iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at www.izafegroup.com
This information is information that iZafe Group is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-12-08 14:45 CET.
Image Attachments
100512242 Dosell Lkemedelsautomat
Attachments
iZafe group has won procurement for pharmaceutical robots potentially worth SEK 5.5-13.8 million
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.SOURCE: iZafe Group
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
15 Companies Pitch Their Capabilities at GA-ASI’s Blue Magic Netherlands2.12.2024 13:00:00 CET | Press release
Nov. 19 Event Hosted by GA-ASI and Supported by Lockheed Martin Ventures and Brainport Attracts Cross-Section of Netherlands' High-Tech Sector SAN DIEGO, CA / ACCESSWIRE / December 2, 2024 / On November 19, 2024, General Atomics Aeronautical Systems, Inc. (GA-ASI) hosted its first Blue Magic Netherlands (BMN) event in Eindhoven, the Netherlands. Approximately 200 people attended the event that provided Dutch businesses with an opportunity to present their capabilities to GA-ASI and other companies interested in possible collaborations. GA-ASI was joined for the event by the Netherlands Ministry of Economic Affairs, the Netherlands Ministry of Defence, Lockheed Martin Ventures, Brainport Development, Brabant Development Agency (BOM), the Netherlands Industries for Defence & Security (NIDV), and SpaceNED. At this event, GA-ASI and its partners heard first-hand from Dutch companies about the important capabilities they are developing. The process started in July when GA-ASI put out an ope
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide2.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of improving patient accessibility and convenience. This product is currently under development and remains subject to regulatory review and approval. Semaglutide: A Proven Therapeutic Leader Semaglutide, developed by Novo Nordisk and marketed under brand names such as Ozempic® and Wegovy®, has revolutionized treatment for Type 2 diabetes and obesity. By mimicking glucagon-like peptide-1 (GLP-1), it enhances insulin secretion, reduces appetite, and slows gastric emptying, offering powerful tools for glycemi
GoodData Launches FlexConnect: Connect to Any Data Source & Transform Data at Run-Time2.12.2024 03:00:00 CET | Press release
SAN FRANCISCO, CA / ACCESSWIRE / December 2, 2024 / Today, GoodData introduces FlexConnect, an advanced component of the GoodData Analytics Lake that redefines data connectivity and computation. FlexConnect enables organizations to: Connect to any data source, including APIs, databases, and ML systems. Execute custom computation logic directly into the data connection using Python, Rust, and other popular languages. Integrate transformed results into GoodData's FlexQuery for further BI computation Render results through any endpoint, GoodData's UI, your UI, or through our APIs and SDKs. "FlexConnect solves a longstanding problem for analytics teams by eliminating the need to wait for vendors to build integrations. With FlexConnect, you can build high-performance connections to a wide range of sources-cloud-based, on-premises, hybrid, SQL, NoSQL, APIs, or machine learning models," said Ryan Dolley, VP of Product Strategy at GoodData. FlexConnect's differentiation lies in its use of Apac
HotelRunner Triumphs as the 'Best Large Technology Supplier' at the Travolution Awards29.11.2024 04:00:00 CET | Press release
HotelRunner, the trailblazing platform for travel and hospitality technologies, has been named the ‘Best Large Technology Supplier' at the Travolution Awards 2024 in the United Kingdom. Selected by the esteemed Travolution Awards jury, this recognition underscores HotelRunner's commitment to innovation and excellence, driving the travel industry forward with data-driven, AI-powered solutions. LONDON, UK / ACCESSWIRE / November 29, 2024 / HotelRunner, the trailblazing platform for travel and hospitality technologies, has been awarded the prestigious "Best Large Technology Supplier" title at the Travolution Awards 2024. The event, held on Nov. 28 in London, celebrated leaders in travel and technology and recognized drivers of innovation and excellence. HotelRunner was selected by a globally respected jury from among six companies competing in the same category, including software companies, tour operator platforms, and SaaS providers. This award recognizes large travel tech companies tha
DEXIS Attends ADF, Showcases Award-Winning Solutions28.11.2024 09:30:00 CET | Press release
QUAKERTOWN, PA / ACCESSWIRE / November 28, 2024 / The latest AI-powered launches from DEXIS enhance diagnostics and patient care. At ADF, DEXIS showcased its innovative product line, including the new intraoral scanners and imaging products. The conference took place November 26-30 at the Palais des Congrès de Paris in Porte Maillot, France. The company's comprehensive range of award-winning solutions covers a complete digital diagnostic workflow, from intraoral scanning and implant planning to sensors, CBCT, and imaging software. With an expanded portfolio and ecosystem, DEXIS Solutions is designed to accelerate workflows, increase productivity, and improve the patient experience. "Our technology makes it easy to organize information and execute treatments, which is at the core of what clinicians expect from us," said DEXIS President, Robert Befidi. "We are connecting and standardizing the implant workflow while also constantly evaluating our efforts to ensure we provide deeper patien
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom